NHIA 2025 Post-Conference Ask the Experts: One Year After the Implementation of USP Revisions - Live 4/23/2025

Includes a Live Web Event on 04/23/2025 at 12:00 PM (EDT)

One year after the implementation of the revised USP <797> standards, this session will provide an in-depth look at the impact of these changes on pharmacy operations, compliance, patient safety, and quality assurance practices. This session presents a unique opportunity to engage directly with industry leaders and experts in sterile compounding. During this interactive panel discussion, experts will address the most pressing challenges and concerns surrounding the revised guidelines, sharing real-world insights and strategies for navigating the evolving regulatory landscape. Attendees will gain valuable knowledge on how to optimize workflows, ensure ongoing compliance, integrate new technologies, and implement best practices to meet the revised standards. Questions not answered during the 2025 NHIA Annual Conference will be addressed in this session.

Learning Objectives:

Identifying common challenges and concerns related to sterile compounding practices and explore expert recommendations for overcoming them.
Deepen understanding of the latest practices through interactive discussion with experts in the field.
Clarify complex issues through direct interaction with experts.

Gene Decaminada, RPh, BSPharm, FNHIA

Pharmacy Manager Home Infusion

Yale New Haven Health

Gene Decaminada is currently the Pharmacy Manager for the Home Infusion Program at Yale New Haven Health Services (YNHHS). NHIA Fellowship Award (2021); CPA mentor (2021, 2022) YNHHS Mentor (2022); NHIA Peer Review Member (2021); CPA Professional Pharmacy Performance Award (2021); BPS Sterile Compounding Council Member (term concluded 12/31/21); former NHIA National Standards and Sterile Compounding Education Committee member; PTCB Certificate Program instructor CT Community College (2021); CPA Sterile Compounding Conference Committee member; NHIA Sterile Compounding Practice Committee (SCPC) member; Vizient Home Infusion subcommittee member; and a selected member of the Institute for Excellence at YNHHS Lean-In Class of 2022.

Patricia Kienle

Cardinal Health

Krystal Stefanyk

North Carolina Board of Pharmacy

Shyla Robinson

Vital Care Inc

Kelly Taylor, PharmD, BCSCP

Carle Health

Kelly Taylor, PharmD, BCSCP is a Clinical Oncology Pharmacist at the Carle Cancer Infusion Clinic at Bromenn Medical Center. Kelly is a UIC alumni and started her professional career at OSF Healthcare in 2002. She held numerous leadership roles within OSF in the inpatient and outpatient infusion areas, as well as the Home Infusion division. Throughout her career, she has led the design/construction of 7 cleanrooms for OSF and served as the Designated Individual responsible for compliance with USP 797/800, as well as TJC and other regulatory requirements for 16 years. She is currently leading the expansion of the Carle Bromenn Outpatient Cancer Infusion Pharmacy and serves as a member of the NHIA Sterile Compounding Committee.

NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.

Kelly Taylor has no relevant financial relationships with ineligible companies to disclose.

Michael Myers

Clinical Support Manager

Contec Healthcare

Michael T. Myers has been with Contec, Inc since 1998 working in various roles including product development, sales management, and technical support. For over a decade he has been focused on helping Sterile Compounding Pharmacies. As the Clinical Support Manager for Contec Healthcare, he focuses on developing educational materials and the in-service teaching of pharmacy technicians – helping them become compliant with USP Chapters <797> and <800>. In 2022 he was awarded the John Martin Outstanding New Member Award by the Institute of Environmental Sciences and Technology (IEST). He holds a Bachelor of Science degree Communications from Appalachian State University.

Michael Myers has no relevant financial relationships with ineligible companies to disclose.